ArticleViruses2021

Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR.

Muneeswaran Selvaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.